Natera, Inc. (NTRA) to Release Quarterly Earnings on Tuesday
Natera, Inc. (NASDAQ:NTRA) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, November 7th. Analysts expect the company to announce earnings of ($0.47) per share for the quarter.
Natera (NASDAQ:NTRA) last issued its quarterly earnings results on Tuesday, August 8th. The medical research company reported ($0.52) EPS for the quarter, hitting the consensus estimate of ($0.52). Natera had a negative net margin of 62.64% and a negative return on equity of 137.46%. The business had revenue of $53.60 million for the quarter, compared to analysts’ expectations of $50.57 million. During the same quarter last year, the company posted ($0.46) earnings per share. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. On average, analysts expect Natera to post $-2.02 EPS for the current fiscal year and $-1.08 EPS for the next fiscal year.
Natera, Inc. (NTRA) opened at 10.68 on Tuesday. Natera, Inc. has a 12 month low of $7.35 and a 12 month high of $14.76. The stock’s 50 day moving average is $12.83 and its 200 day moving average is $12.83. The company’s market cap is $568.42 million.
In other news, insider Jonathan Sheena sold 120,000 shares of Natera stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $12.54, for a total transaction of $1,504,800.00. Following the sale, the insider now directly owns 533,208 shares in the company, valued at approximately $6,686,428.32. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 12.57% of the stock is currently owned by insiders.
Several research analysts have recently issued reports on NTRA shares. ValuEngine downgraded shares of Natera from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. Zacks Investment Research upgraded shares of Natera from a “sell” rating to a “buy” rating and set a $15.00 price objective on the stock in a report on Wednesday, October 11th. BidaskClub downgraded shares of Natera from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Robert W. Baird restated a “buy” rating on shares of Natera in a report on Tuesday, October 24th. Finally, Morgan Stanley restated an “overweight” rating and set a $16.00 price objective (up previously from $13.00) on shares of Natera in a report on Friday, October 6th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $16.20.
Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.